Please add "" to your Email Address Book. Learn how.

January is National Pancreatic Cancer Clinical Trials Awareness Month.

» Learn more.
Find an Appropriate Clinical Trial
Let us help you find a pancreatic cancer clinical trial that may be right for you.
Answers to Your Questions
Speak with a PALS Associate to get the answers, information and resources that you need.
Resolve to Get Involved
Whether you have five minutes or more time for an extended commitment, we have a volunteer opportunity for you.
Congress Soon Returns to D.C.
Tell your U.S. Representative and Senators it is important that they get to work right away on pancreatic cancer legislation.
Kick off 2012
in Purple

Show your support by sporting one of our eye-catching new football jerseys. Shop now for this and other colorful apparel.
Renowned cancer biology expert Lynn Matrisian, PhD, has joined the organization as Vice President, Scientific and Medical Affairs. Learn more.
Pay Tribute to
Your Loved One

Find out about the many different ways you can donate and support our ongoing efforts to fight the disease.
Fandango's Facebook Tribute
The company honored Steve Jobs' memory by donating $1 to the cause for each person who "liked" its Facebook tribute. Learn more.

A Message from the President and CEO

Jordan Berlin, MD, is our guest columnist for this month's edition of Pancreas Matters. He is a Medical Oncologist, Professor of Medicine, and Clinical Director of the GI Oncology Program at the Vanderbilt-Ingram Cancer Center. Dr. Berlin has also been a member of the Pancreatic Cancer Action Network Medical Advisory Board since 2006 and is currently serving as its Chair. He has a strong interest in the design of effective clinical trials and is a dedicated advocate for patient participation.

Julie Fleshman, JD, MBA
President and CEO
Pancreatic Cancer Action Network

Dear Pancreatic Cancer Action Network Friends:

January has been deemed National Pancreatic Cancer Clinical Trial Awareness Month by the Pancreatic Cancer Action Network in an effort to heighten awareness about the importance of clinical trial participation. To reach our goal of doubling the survival rate of pancreatic cancer by the year 2020, we need to continue to increase private and federal dollars for pancreatic cancer research that will lead to innovative clinical trials. We also need to increase patients' participation in clinical trials for pancreatic cancer.

As we all know, the currently available treatment options for pancreatic cancer are inadequate to fight this deadly disease. The only way to improve upon our arsenal of therapeutics is to test new treatments through a rigorous clinical trials process. Research conducted in the laboratory followed by observations made in the clinic allow for the development of novel treatments that are safe and more effective than what is currently available.

My theory has always been that a team approach is better than the sum of its parts. For progress to be made in the fight against pancreatic cancer, we'll need the participation of patients and their caregivers, researchers, doctors, funding organizations and other medical professionals.

I wholeheartedly support the Pancreatic Cancer Action Network's position that all patients should consider clinical trials when exploring treatment options. The National Comprehensive Cancer Network's Guidelines for the treatment of pancreatic cancer states that clinical trials are the preferred option for treatment. Without clinical trials, we will not be able to develop new drugs and new treatments that will lead to the improved survival and the cure rate we all want to see.

The Pancreatic Cancer Action Network's Patient and Liaison Services (PALS) program has incredible resources to help patients find clinical trials that may best match their needs. Click to learn more about clinical trials. You can also start your personalized clinical trials search from this page. Or, contact a PALS Associate directly toll-free at 877-272-6226 or PALS Associates are available M-F 7am-5pm Pacific Time.

Thank you for your support of the Pancreatic Cancer Action Network and for promoting awareness about clinical trials throughout this month and into the future. Your participation in clinical trials could have a positive impact on your treatment, will help speed scientific progress toward therapeutic breakthroughs for those who have yet to be diagnosed, and will provide hope for countless patients and families affected by this devastating disease. Together, we can all make progress in the fight against pancreatic cancer.

Wishing you all the best in 2012,

Jordan Berlin, MD
Medical Advisory Board Chair
Pancreatic Cancer Action Network


For information about including the Pancreatic Cancer Action Network in your estate planning,
click here.


Privacy Policy       Unsubscribe